MedPath

Lamotrigine

Brand Name: Lamotrigine

Generic Name: Lamepil-25

Active
Registration Number

DRP-6770

Dosage Form

Tablet

Issuance Date

May 21, 2021

Expiry Date

July 27, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength25 mg
PackagingAlu/Clear PVC Blister Pack x 14's (Box of 28's)

Classification

C
Classification
Prescription Drug (RX)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Lamepil-25Active
Monograph: lamepil-25

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform